3 results
Approved WMOPending
To assess the safety of treatment with escalating dosages of VELCADE in combination with ZARNESTRA in subjects with Intermediate-2 or high risk MDS according to the IPSS classification.
Approved WMOCompleted
Primary objective: To determine the antitumor activity regarding objective response rate (ORR) of tipifarnib in subjects with locally advanced non-resectable or metastatic, relapsed and/or refractory, non-haematological malignancies with HRAS…
Not approvedWill not start
To validate the method of measuring torsional eye movementsTo measure 3D eye movementsTo assess the age dependency of the responsesTo measure the gain of eye- versus headmovement and retinal slip velocity in clinical diagnosis by comparing patients…